Unger, Marcus M.

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 1,159

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease

Schwiertz, A., Spiegel, J., Dillmann, U., Grundmann, D., Bürmann, J., Faßbender, K., Schäfer, K.-H., & Unger, M. M. (2018) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 318

Effect of Parkinson’s Disease and Related Medications on the Composition of the Fecal Bacterial Microbiota

Weis, S., Schwiertz, A., Unger, M. M., Becker, A., Faßbender, K., Ratering, S., Kohl, M., Schnell, S., Schäfer, K.-H., & Egert, M. (2019) · npj Parkinson s Disease

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 145

Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study

Ferini-Strambi, L., Oertel, W., Dauvilliers, Y., Postuma, R. B., Marelli, S., Iranzo, A., Arnulf, I., Birgit, H., Manni, R., Miyamoto, T., et al. (2014) · Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 112

Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial

Becker, A., Schmartz, G. P., Gröger, L., Grammes, N., Galata, V., Philippeit, H., Weiland, J., Ludwig, N., Meese, E., Tierling, S., et al. (2022) · Genomics, Proteomics & Bioinformatics

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 102

Effects of Resistant Starch on Symptoms, Fecal Markers and Gut Microbiota in Parkinson’s Disease – The RESISTA-PD Trial

Becker, A., Schmartz, G. P., Gröger, L., Grammes, N., Galata, V., Philippeit, H., Weiland, J., Ludwig, N., Meese, E., Tierling, S., et al. (2021) · Genomics Proteomics & Bioinformatics

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 102

Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?

Unger, M. M., Möller, J. C., Mankel, K., Eggert, K. M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P. H., Mayer, G., Tebbe, J. J., et al. (2011) · Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsRegulation of Appetite and Obesity

Cited by 97